Physician profile
Andrea E Bowen
NPI 1083812697
$1,219.54
in general payments reported to CMS, 2019-2025
8 companies · $19.94 in 2025
The $19.94 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.83 · 2020: $145 · 2021: $169 · 2022: $458 · 2023: $315 · 2024: $54.72 · 2025: $19.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $343.77 | 2021-2024 | Vraylar |
| Janssen Pharmaceuticals, INC | $296.10 | 2019-2023 | Invega Sustenna, Invega Trinza, Spravato |
| Otsuka America Pharmaceutical, INC. | $256.60 | 2020-2023 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Alkermes, INC. | $182.90 | 2019-2023 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $64.10 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $39.42 | 2024-2025 | Cobenfy |
| Indivior INC. | $25.68 | 2023 | Perseris |
| Allergan, INC. | $10.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Bowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.